Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators.
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
[Device-device interaction].
Johnson V, Hamm CW, Schmitt J.
Herzschrittmacherther Elektrophysiol. 2019 Jun;30(2):183-190. doi: 10.1007/s00399-019-0617-z. Epub 2019 Apr 15.
Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
Black-Maier E, Lewis RK, Rehorn M, Loungani R, Friedman DJ, Frazier-Mills C, Jackson KP, Atwater BD, Milano CA, Schroder JN, Pokorney SD, Piccini JP.
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1509-1518. doi: 10.1111/jce.14487. Epub 2020 Apr 29.
Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM.
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):582-90. doi: 10.1161/CIRCOUTCOMES.113.000299. Epub 2013 Sep 3.
Ventricular tachyarrhythmia induction by strong cardiac shocks: can understanding underlying mechanisms lead to improved prevention of defibrillator failure?
Nattel S.
Heart Rhythm. 2006 May;3(5):596-7. doi: 10.1016/j.hrthm.2006.03.024. Epub 2006 Mar 28.
Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.
Providência R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, Novak J, Hauser RG, Lambiase PD.
J Am Heart Assoc. 2015 Oct 30;4(11):e002418. doi: 10.1161/JAHA.115.002418.
Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C, Palano F, Silvetti G, Cosentino P, Francia P.
High Blood Press Cardiovasc Prev. 2020 Aug;27(4):291-297. doi: 10.1007/s40292-020-00394-x. Epub 2020 Jun 9.
Implantable cardioverter-defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve) implantation.
Plant A, Stewart F, Hooks D.
J Cardiovasc Electrophysiol. 2024 May;35(5):1050-1054. doi: 10.1111/jce.16249. Epub 2024 Mar 19.
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely B, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Zhang Y, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators.
Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26.
Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.
Link MS, Sullivan RM, Olshansky B, Cannom D, Berul CI, Hauser RG, Heidbuchel H, Jordaens L, Krahn AD, Morgan J, Patton KK, Saarel EV, Wilkoff BL, Li F, Dziura J, Brandt C, Barth C, Lampert R.
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009344. doi: 10.1161/CIRCEP.120.009344. Epub 2021 Mar 16.
